Literature DB >> 3458113

Prognostic significant of functional defects of granulocytes in myeloproliferative disease.

A Mazzone, G Ricevuti, M Rossi, S C Rizzo.   

Abstract

Patients suffering from myeloproliferative diseases are frequently susceptible to infection. We studied granulocyte function and cytogenetics in 32 patients with different myeloproliferative syndromes. In vivo granulocyte function was studied in 10 patients using the skin window technique. Our data demonstrate a deficit in chemotaxis (p less than 0.001) which does not seem to correlate with any specific chromosomal anomaly. Patients showing a deficit in myeloperoxidase activity, phagocytosis, O2- production or NBT reduction also had a much lower median survival with respect to other patients treated with the same protocol but without these deficits (p less than 0.01). By conducting granulocyte function studies at diagnosis one may therefore isolate those patients with an increased risk of contracting infections and a decreased probability of complete remission.

Entities:  

Mesh:

Year:  1986        PMID: 3458113     DOI: 10.1159/000226359

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  3 in total

1.  In vivo and in vitro HeNe laser effects on phagocyte functions.

Authors:  G Ricevuti; A Mazzone; C Monaia; P Fratino; R Degiulio; R Dell'Acqua; G Leonardi; A Jucci; S Sacchi
Journal:  Inflammation       Date:  1989-10       Impact factor: 4.092

2.  Effect of piroxicam therapy on granulocyte function and granulocyte elastase concentration in peripheral blood and synovial fluid of rheumatoid arthritis patients.

Authors:  C Montecucco; A Mazzone; D Pasotti; R Caporali; M Longhi; D Casilli; G Ricevuti; P Fratino; M P Ruffilli
Journal:  Inflammation       Date:  1989-04       Impact factor: 4.092

3.  Effect of a factor released by K562 malignant cells in culture on human neutrophil bactericidal activity.

Authors:  M Amar; N Amit; C Babin-Chevaye; T P Huu; J Hakim
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.